Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/pseudoprogression-of-brain-tumors-4QOsib4zPW
References (140)
-
(2014)
The role of imaging in the management of progressive glioblastoma?: A systematic review and evidence‐based clinical practice guideline, 118
-
L. Zach, D. Guez, D. Last, D. Daniels, Y. Grober, O. Nissim, C. Hoffmann, D. Nass, A. Talianski, R. Spiegelmann, Z. Cohen, Y. Mardor (2012)
Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Primary and Metastatic Brain TumorsPLoS ONE, 7
-
Zhi-cheng Liu, Lin-Feng Yan, Yu-Chuan Hu, Ying-Zhi Sun, Qiang Tian, Hai-Yan Nan, Ying Yu, Qian Sun, Wen Wang, Guang-Bin Cui (2017)
Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trialBMC Medical Imaging, 17
-
C. Varallyay, E. Nesbit, A. Horváth, P. Várallyay, R. Fu, S. Gahramanov, L. Muldoon, Xin Li, W. Rooney, E. Neuwelt (2018)
Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of careJournal of Magnetic Resonance Imaging, 48
-
C. Gzell, H. Wheeler, P. Mccloud, M. Kastelan, M. Back (2016)
Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastomaJournal of Neuro-Oncology, 128
-
Bo Ma, J. Blakeley, Xiaohua Hong, Hongyan Zhang, Shanshan Jiang, L. Blair, Yi Zhang, H. Heo, Mingzhi Zhang, P. Zijl, Jinyuan Zhou (2016)
Applying amide proton transfer‐weighted MRI to distinguish pseudoprogression from true progression in malignant gliomasJournal of Magnetic Resonance Imaging, 44
-
N. Anzalone, A. Castellano, M. Cadioli, G. Conte, V. Cuccarini, A. Bizzi, M. Grimaldi, Antonella Costa, G. Grillea, P. Vitali, D. Aquino, M. Terreni, V. Torri, B. Erickson, M. Caulo (2018)
Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.Radiology, 287 3
-
E. Matsusue, J. Fink, J. Rockhill, T. Ogawa, K. Maravilla (2010)
Distinction between glioma progression and post-radiation change by combined physiologic MR imagingNeuroradiology, 52
-
D. Kong, S.T. Kim, E. Kim, D. Lim, W. Kim, Y. Suh, J. Lee, K. Park, J.H. Kim, D. Nam (2011)
Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation StatusAmerican Journal of Neuroradiology, 32
-
D. Westen, E. Petersen, R. Wirestam, R. Siemund, K. Bloch, F. Ståhlberg, I. Björkman-Burtscher, Linda Knutsson (2011)
Correlation between arterial blood volume obtained by arterial spin labelling and cerebral blood volume in intracranial tumoursMagnetic Resonance Materials in Physics, Biology and Medicine, 24
-
I. Melguizo-Gavilanes, J. Bruner, N. Guha-Thakurta, K. Hess, V. Puduvalli (2010)
Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?Journal of Neuro-Oncology, 123
-
J. Park, H. Kim, M. Goh, Sang Kim, Jeong Kim (2015)
Pseudoprogression in Patients with Glioblastoma: Assessment by Using Volume-weighted Voxel-based Multiparametric Clustering of MR Imaging Data in an Independent Test Set.Radiology, 275 3
-
S. Gahramanov, L. Muldoon, C. Varallyay, Xin Li, D. Kraemer, R. Fu, Bronwyn Hamilton, W. Rooney, E. Neuwelt (2013)
Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.Radiology, 266 3
-
E. Zacharaki, Sumei Wang, S. Chawla, Dong Yoo, R. Wolf, E. Melhem, C. Davatzikos (2009)
Classification of brain tumor type and grade using MRI texture and shape in a machine learning schemeMagnetic Resonance in Medicine, 62
-
C. Varallyay, G.B. Toth, R. Fu, J. Netto, J. Firkins, P. Ambady, E. Neuwelt (2017)
What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast AgentAmerican Journal of Neuroradiology, 38
-
S. Bulnes, Juan Bilbao, J. Lafuente (2009)
Microvascular adaptive changes in experimental endogenous brain gliomas.Histology and histopathology, 24 6
-
T. Kazda, M. Bulik, P. Pospíšil, R. Lakomy, M. Smrcka, P. Šlampa, R. Jancalek (2016)
Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imagingNeuroImage : Clinical, 11
-
V. Guivel-Scharen, T. Sinnwell, S. Wolff, R. Balaban (1998)
Detection of proton chemical exchange between metabolites and water in biological tissues.Journal of magnetic resonance, 133 1
-
S. Bisdas, T. Naegele, R. Ritz, Artemisia Dimostheni, C. Pfannenberg, M. Reimold, T. Koh, U. Ernemann (2011)
Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging.Academic radiology, 18 5
-
R. Grossman, N. Shimony, U. Hadelsberg, D. Soffer, R. Sitt, N. Strauss, B. Corn, Z. Ram (2016)
Impact of Resecting Radiation Necrosis and Pseudoprogression on Survival of Patients with Glioblastoma.World neurosurgery, 89
-
J. Boxerman, K. Schmainda, R. Weisskoff (2006)
Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.AJNR. American journal of neuroradiology, 27 4
-
H. Baek, H. Kim, Namkug Kim, Y. Choi, Young Kim (2012)
Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas.Radiology, 264 3
-
M. Pinho, P. Polášková, Jayashree Kalpathy-Cramer, Dominique Jennings, K. Emblem, R. Jain, B. Rosen, P. Wen, A. Sorensen, T. Batchelor, E. Gerstner (2013)
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.The oncologist, 19 1
-
Jens Petersen, M. Bendszus, J. Debus, S. Heiland, Klaus Maier-Hein (2017)
Effective user interaction in online interactive semantic segmentation of glioblastoma magnetic resonance imagingJournal of Medical Imaging, 4
-
H. Kwak, S. Hwang, G. Chung, Ji-Soo Song, E. Choi (2015)
Detection of small brain metastases at 3 T: comparing the diagnostic performances of contrast-enhanced T1-weighted SPACE, MPRAGE, and 2D FLASH imaging.Clinical imaging, 39 4
-
R. Stupp, M. Hegi, W. Mason, M. Bent, M. Taphoorn, R. Janzer, S. Ludwin, A. Allgeier, B. Fisher, K. Bélanger, P. Hau, A. Brandes, J. Gijtenbeek, C. Marosi, C. Vecht, K. Mokhtari, P. Wesseling, S. Villà, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. Cairncross, R. Mirimanoff (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.The Lancet. Oncology, 10 5
-
M. Grade, J. Tamames, F. Pizzini, E. Achten, X. Golay, M. Smits (2015)
A neuroradiologist’s guide to arterial spin labeling MRI in clinical practiceNeuroradiology, 57
-
Alissa Thomas, J. Arevalo-Perez, T. Kaley, J. Lyo, K. Peck, W. Shi, Zhigang Zhang, R. Young (2015)
Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastomaJournal of Neuro-Oncology, 125
-
K. Furutani, M. Harada, Mahmut Mawlan, H. Nishitani (2008)
Difference in Enhancement Between Spin Echo and 3-Dimensional Fast Spoiled Gradient Recalled Acquisition in Steady State Magnetic Resonance Imaging of Brain Metastasis at 3-T Magnetic Resonance ImagingJournal of Computer Assisted Tomography, 32
-
J. Cha, S. Kim, Hyung-Jin Kim, Hyejung Kim, Byung-joon Kim, P. Jeon, K. Kim, H. Byun (2012)
Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progressionEuropean Radiology, 23
-
K. Jafari-Khouzani, F. Loebel, W. Bogner, O. Rapalino, Gilberto González, E. Gerstner, A. Chi, T. Batchelor, B. Rosen, J. Unkelbach, H. Shih, D. Cahill, O. Andronesi (2016)
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.Neuro-oncology, 18 11
-
(2007)
Pseudoprogression after concomitant radio-chemotherapy treatment in newly diagnosed glioblastoma patients and potential correlation with MGMT methylation status -
Yuanyu Shen, G. Xiao, Zhiwei Shen, Xiaolei Zhang, Xiangyong Tang, Wei Hu, Zhiyan Zhang, Jitian Guan, R. Wu (2017)
Imaging of nuclear Overhauser enhancement at 7 and 3 TNMR in Biomedicine, 30
-
T. Sugahara, Y. Korogi, M. Kochi, I. Ikushima, T. Hirai, T. Okuda, Y. Shigematsu, L. Liang, Y. Ge, Yukitaka Ushio, Mutsumasa Takahashi (1998)
Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.AJR. American journal of roentgenology, 171 6
-
A. Server, B. Kulle, Ø. Gadmar, R. Josefsen, T. Kumar, P. Nakstad (2011)
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.European journal of radiology, 80 2
-
D. Reardon, K. Ballman, J. Buckner, Susan Chang, B. Ellingson (2014)
Impact of imaging measurements on response assessment in glioblastoma clinical trials.Neuro-oncology, 16 Suppl 7
-
Ashok Kumar, Norman Leeds, Gregory Fuller, P. Tassel', M. Maor, Raymond Sawaya, Victor Levin (2000)
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.Radiology, 217 2
-
Sophie West, H. Bruin, B. Langerijt, A. Swaak-Kragten, M. Bent, W. Taal (2016)
Incidence of pseudoprogression in low-grade gliomas treated with radiotherapyNeuro-Oncology, 19
-
K. Plate, H. Mennel (1995)
Vascular morphology and angiogenesis in glial tumors.Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 47 2-3
-
D. Brandsma, L. Stalpers, W. Taal, P. Sminia, M. Bent (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.The Lancet. Oncology, 9 5
-
B. Ellingson, C. Chung, W. Pope, J. Boxerman, T. Kaufmann (2017)
Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscapeJournal of Neuro-Oncology, 134
-
P. Weybright, P. Sundgren, P. Maly, D. Hassan, B. Nan, S. Rohrer, L. Junck (2005)
Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.AJR. American journal of roentgenology, 185 6
-
M. Mullins, G. Barest, P. Schaefer, F. Hochberg, R. González, M. Lev (2005)
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.AJNR. American journal of neuroradiology, 26 8
-
Jing Ye, S. Bhagat, Hongmei Li, X. Luo, Buhai Wang, Liqin Liu, Guomei Yang (2016)
Differentiation between recurrent gliomas and radiation necrosis using arterial spin labeling perfusion imaging.Experimental and therapeutic medicine, 11 6
-
Xin Chen, Xinhua Wei, Zhongping Zhang, Ruimeng Yang, Yanjie Zhu, Xin-qing Jiang (2015)
Differentiation of true-progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide by GLCM texture analysis of conventional MRI.Clinical imaging, 39 5
-
Alsop (2015)
10.1002/mrm.25197Magn Reson Med, 73
-
J. Rock, D. Hearshen, L. Scarpace, D. Croteau, J. Gutierrez, J. Fisher, M. Rosenblum, T. Mikkelsen (2002)
Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation NecrosisNeurosurgery, 51
-
D. Hamstra, C. Galbán, C. Meyer, T. Johnson, P. Sundgren, C. Tsien, T. Lawrence, L. Junck, David Ross, A. Rehemtulla, B. Ross, T. Chenevert (2008)
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 20
-
K. Welker, J. Boxerman, A. Kalnin, T. Kaufmann, M. Shiroishi, Max Wintermark (2015)
ASFNR Recommendations for Clinical Performance of MR Dynamic Susceptibility Contrast Perfusion Imaging of the BrainAmerican Journal of Neuroradiology, 36
-
Abdul Abbasi, H. Westerlaan, G. Holtman, Kamal Aden, P. Laar, A. Hoorn (2017)
Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-AnalysisClinical Neuroradiology, 28
-
A. Larroza, D. Moratal, A. Paredes-Sánchez, E. Soria-Olivas, M. Chust, L. Arribas, E. Arana (2015)
Support vector machine classification of brain metastasis and radiation necrosis based on texture analysis in MRIJournal of Magnetic Resonance Imaging, 42
-
Silun Wang, Yifei Chen, B. Lal, E. Ford, E. Tryggestad, M. Armour, K. Yan, J. Laterra, Jinyuan Zhou (2012)
Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imagingJournal of Neuro-Oncology, 107
-
B. Ellingson, M. Bendszus, J. Boxerman, D. Barboriak, B. Erickson, M. Smits, S. Nelson, E. Gerstner, B. Alexander, G. Goldmacher, W. Wick, M. Vogelbaum, M. Weller, E. Galanis, Jayashree Kalpathy-Cramer, L. Shankar, P. Jacobs, W. Pope, Dewen Yang, C. Chung, M. Knopp, S. Cha, M. Bent, Susan Chang, W. Yung, T. Cloughesy, P. Wen, M. Gilbert (2015)
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.Neuro-oncology, 17 9
-
Leland Hu, J. Eschbacher, J. Heiserman, A. Dueck, W. Shapiro, Seban Liu, J. Karis, Kris Smith, S. Coons, P. Nakaji, R. Spetzler, B. Feuerstein, J. Debbins, L. Baxter (2012)
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survivalNeuro-Oncology, 14
-
A. Radbruch, J. Fladt, P. Kickingereder, B. Wiestler, M. Nowosielski, P. Bäumer, H. Schlemmer, A. Wick, S. Heiland, W. Wick, M. Bendszus (2015)
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence.Neuro-oncology, 17 1
-
E. Gasparetto, M. Pawlak, Sohil Patel, J. Huse, J. Woo, J. Krejza, M. Rosenfeld, D. O’Rourke, R. Lustig, E. Melhem, R. Wolf (2009)
Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.Radiology, 250 3
-
W. Wick, O. Chinot, M. Bendszus, W. Mason, R. Henriksson, F. Saran, R. Nishikawa, C. Révil, Y. Kerloeguen, T. Cloughesy (2016)
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.Neuro-oncology, 18 10
-
J. Khalifa, F. Tensaouti, J. Lotterie, I. Catalaa, L. Chaltiel, A. Benouaich‐Amiel, C. Gomez-Roca, G. Noël, G. Truc, P. Péran, I. Berry, M. Sunyach, M. Charissoux, Corinne Johnson, E. Moyal, A. Laprie (2016)
Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?Journal of Neuro-Oncology, 130
-
Qiuting Wen, D. Kelley, Suchandrima Banerjee, J. Lupo, Susan Chang, Duan Xu, C. Hess, S. Nelson (2015)
Clinically feasible NODDI characterization of glioma using multiband EPI at 7 TNeuroImage : Clinical, 9
-
T. Booth, T. Larkin, Yinyin Yuan, M. Kettunen, Sarah Dawson, D. Scoffings, Holly Canuto, S. Vowler, H. Kirschenlohr, M. Hobson, F. Markowetz, S. Jefferies, K. Brindle (2017)
Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastomaPLoS ONE, 12
-
R. Yoo, S. Choi, Tae Kim, Sun-Do Lee, Chul-Kee Park, Sung-Hye Park, Il Kim, T. Yun, Ji-hoon Kim, C. Sohn (2015)
Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC ValueAmerican Journal of Neuroradiology, 36
-
C. Lopez, N. Nagornaya, N. Parra, D. Kwon, F. Ishkanian, A. Markoe, A. Maudsley, R. Stoyanova (2017)
Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.International journal of radiation oncology, biology, physics, 97 3
-
D. Black, J. Morris, E. Lindell, K. Krecke, G. Worrell, J. Bartleson, D. Lachance (2013)
Stroke-Like Migraine Attacks after Radiation Therapy (SMART) Syndrome Is Not Always Completely Reversible: A Case SeriesAmerican Journal of Neuroradiology, 34
-
V. Levin, L. Bidaut, P. Hou, Ashok Kumar, J. Wefel, B. Bekele, Jai Grewal, S. Prabhu, M. Loghin, M. Gilbert, E. Jackson (2011)
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.International journal of radiation oncology, biology, physics, 79 5
-
J. Ruben, M. Dally, M. Bailey, Robin Smith, C. Mclean, P. Fedele (2006)
Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy.International journal of radiation oncology, biology, physics, 65 2
-
E. Topkan, S. Topuk, E. Oymak, C. Parlak, B. Pehlivan (2012)
Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and TemozolomideAmerican Journal of Clinical Oncology, 35
-
Y. Song, S. Choi, Chul-Kee Park, Kyung Yi, W. Lee, T. Yun, T. Kim, Se-Hoon Lee, Ji-hoon Kim, C. Sohn, Sung-Hye Park, I. Kim, G. Jahng, K. Chang (2013)
True Progression versus Pseudoprogression in the Treatment of Glioblastomas: A Comparison Study of Normalized Cerebral Blood Volume and Apparent Diffusion Coefficient by Histogram AnalysisKorean Journal of Radiology, 14
-
M. Wit, H. Bruin, W. Eijkenboom, P. Smitt, M. Bent, Sillevis Smitt, Van Bent, Radiotherapy Bruin (2004)
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progressionNeurology, 63
-
Leland Hu, L. Baxter, Kris Smith, B. Feuerstein, J. Karis, J. Eschbacher, S. Coons, P. Nakaji, R. Yeh, J. Debbins, J. Heiserman (2009)
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging MeasurementsAmerican Journal of Neuroradiology, 30
-
E. Paulson, K. Schmainda (2008)
Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.Radiology, 249 2
-
S. Wang, M. Martinez-Lage, Y. Sakai, S. Chawla, S. Kim, M. Alonso-Basanta, R. Lustig, S. Brem, S. Mohan, R. Wolf, A. Desai, Harish Poptani (2015)
Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRIAmerican Journal of Neuroradiology, 37
-
V. Chiou, M. Burotto (2015)
Pseudoprogression and Immune-Related Response in Solid Tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 31
-
K. Nael, Adam Bauer, A. Hormigo, M. Lemole, I. Germano, J. Puig, B. Stea (2018)
Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma.AJR. American journal of roentgenology, 210 1
-
P. Zijl, Jinyuan Zhou, N. Mori, J. Payen, David Wilson, S. Mori (2003)
Mechanism of magnetization transfer during on‐resonance water saturation. A new approach to detect mobile proteins, peptides, and lipidsMagnetic Resonance in Medicine, 49
-
T. Sugahara, Y. Korogi, S. Tomiguchi, Y. Shigematsu, I. Ikushima, T. Kira, L. Liang, Yukitaka Ushio, Mutsumasa Takahashi (2000)
Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.AJNR. American journal of neuroradiology, 21 5
-
B. Ellingson, M. Malkin, S. Rand, J. Connelly, C. Quinsey, P. LaViolette, D. Bedekar, K. Schmainda (2010)
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularityJournal of Magnetic Resonance Imaging, 31
-
Hanna Järnum, E. Steffensen, Linda Knutsson, E. Fründ, C. Simonsen, S. Lundbye-Christensen, A. Shankaranarayanan, D. Alsop, F. Jensen, E. Larsson (2010)
Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imagingNeuroradiology, 52
-
Y. Heo, H. Kim, J. Park, C. Choi, Sang Kim (2015)
Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging OptionsPLoS ONE, 10
-
M. Bulik, T. Kazda, P. Šlampa, R. Jancalek (2015)
The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient MappingBioMed Research International, 2015
-
Pierre Lehmann, P. Monet, G. Marco, G. Saliou, M. Perrin, S. Stoquart-ElSankari, A. Bruniau, Jean-Noël Vallée (2010)
A Comparative Study of Perfusion Measurement in Brain Tumours at 3 Tesla MR: Arterial Spin Labeling versus Dynamic Susceptibility Contrast-Enhanced MRIEuropean Neurology, 64
-
H. Chu, Seung-Hong Choi, I. Ryoo, Soo Kim, J. Yeom, Hwaseon Shin, S. Jung, A. Lee, Tae Yoon, Tae Kim, Se-Hoon Lee, Chul-Kee Park, Ji-hoon Kim, C. Sohn, Sung-Hye Park, I. Kim (2013)
Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.Radiology, 269 3
-
N. Danchaivijitr, A. Waldman, D. Tozer, C. Benton, Gisele Caseiras, P. Tofts, J. Rees, H. Jäger (2008)
Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?Radiology, 247 1
-
W. Lee, S. Choi, Chul-Kee Park, Kyung Yi, T. Kim, Se-Hoon Lee, Ji-hoon Kim, C. Sohn, Sung-Hye Park, I. Kim (2012)
Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.Academic radiology, 19 11
-
(2016)
Imaging of Brain Tumors, An Issue of Magnetic Resonance Imaging Clinics of North America, E-Book -
P. Tofts, G. Brix, D. Buckley, J. Evelhoch, E. Henderson, M. Knopp, H. Larsson, Ting-Yim Lee, N. Mayr, G. Parker, R. Port, June Taylor, R. Weisskoff (1999)
Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbolsJournal of Magnetic Resonance Imaging, 10
-
E. Karavaeva, R. Harris, K. Leu, Maryam Shabihkhani, W. Yong, W. Pope, A. Lai, P. Nghiemphu, L. Liau, Wei Chen, J. Czernin, T. Cloughesy, B. Ellingson (2015)
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant GliomasMolecular Imaging and Biology, 17
-
D. Alsop, J. Detre, X. Golay, M. Günther, J. Hendrikse, L. Hernandez-Garcia, Hanzhang Lu, B. MacIntosh, L. Parkes, M. Smits, M. Osch, Danny Wang, E. Wong, G. Zaharchuk (2015)
Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.Magnetic resonance in medicine, 73 1
-
C. Balañà, J. Capellades, E. Pineda, A. Estival, J. Puig, Sira Domenech, E. Verger, T. Pujol, M. Martínez-García, L. Oleaga, J. Velarde, C. Mesía, R. Fuentes, J. Marruecos, S. Barco, S. Villà, C. Carrato, O. Gallego, M. Gil-Gil, J. Craven-Bartle, F. Alameda (2017)
Pseudoprogression as an adverse event of glioblastoma therapyCancer Medicine, 6
-
A. Chaddad, C. Tanougast (2016)
Extracted magnetic resonance texture features discriminate between phenotypes and are associated with overall survival in glioblastoma multiforme patientsMedical & Biological Engineering & Computing, 54
-
H. Nguyen, N. Milbach, S.L. Hurrell, E. Cochran, J. Connelly, J. Bovi, C. Schultz, W. Mueller, S. Rand, K. Schmainda, P. LaViolette (2016)
Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent GlioblastomaAmerican Journal of Neuroradiology, 37
-
D. Patterson, A. Padhani, D. Collins (2008)
Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapyNature Clinical Practice Oncology, 5
-
O. Togao, T. Yoshiura, J. Keupp, A. Hiwatashi, K. Yamashita, K. Kikuchi, Yuriko Suzuki, Satoshi Suzuki, T. Iwaki, N. Hata, M. Mizoguchi, K. Yoshimoto, Koji Sagiyama, Masaya Takahashi, H. Honda (2014)
Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.Neuro-oncology, 16 3
-
U. Löbel, S. Hwang, Alexander Edwards, You Li, Xingfeng Li, A. Broniscer, Z. Patay (2016)
Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategiesNeuroradiology, 58
-
Hui Zhang, Li Ma, Qun Wang, Xu Zheng, Chen Wu, Bai⁃nan Xu (2014)
Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis.European journal of radiology, 83 12
-
M. Zaiss, J. Windschuh, D. Paech, J. Meissner, Sina Burth, B. Schmitt, P. Kickingereder, B. Wiestler, W. Wick, M. Bendszus, H. Schlemmer, M. Ladd, P. Bachert, A. Radbruch (2015)
Relaxation-compensated CEST-MRI of the human brain at 7T: Unbiased insight into NOE and amide signal changes in human glioblastomaNeuroImage, 112
-
Y. Ozsunar, M. Mullins, K. Kwong, F. Hochberg, C. Ament, P. Schaefer, R. González, M. Lev (2010)
Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.Academic radiology, 17 3
-
M. Shiroishi, J. Boxerman, W. Pope (2016)
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Neuro-oncology, 18 4
-
A. Padhani, Guoying Liu, D. Koh, T. Chenevert, H. Thoeny, T. Takahara, A. Dzik-Jurasz, B. Ross, M. Cauteren, D. Collins, D. Hammoud, G. Rustin, B. Taouli, P. Choyke (2009)
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.Neoplasia, 11 2
-
Heather McConnell, D. Schwartz, Brian Richardson, R. Woltjer, L. Muldoon, E. Neuwelt (2016)
Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.Nanomedicine : nanotechnology, biology, and medicine, 12 6
-
A. Seeger, Christian Braun, M. Skardelly, F. Paulsen, J. Schittenhelm, U. Ernemann, S. Bisdas (2013)
Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.Academic radiology, 20 12
-
T. Hirai, M. Kitajima, H. Nakamura, T. Okuda, A. Sasao, Y. Shigematsu, D. Utsunomiya, S. Oda, H. Uetani, M. Morioka, Y. Yamashita (2011)
Quantitative Blood Flow Measurements in Gliomas Using Arterial Spin-Labeling at 3T: Intermodality Agreement and Inter- and Intraobserver Reproducibility StudyAmerican Journal of Neuroradiology, 32
-
Hui Zhang, Li Ma, C. Shu, Yu-bo Wang, Lian-qiang Dong (2015)
Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from radiation necrosisJournal of the Neurological Sciences, 351
-
Mousa Anbarloui, S. Ghodsi, A. Khoshnevisan, M. Khadivi, S. Abdollahzadeh, Ahmad Aoude, S. Naderi, Z. Najafi, Morteza Faghih-Jouibari (2015)
Accuracy of magnetic resonance spectroscopy in distinction between radiation necrosis and recurrence of brain tumorsIranian Journal of Neurology, 14
-
R. Colen, P. Zinn, Saman Hazany, D. Do-Dai, Julian Wu, Kevin Yao, Jay-Jiguang Zhu (2011)
Magnetic resonance imaging appearance and changes on intracavitary Gliadel wafer placement: A pilot study.World journal of radiology, 3 11
-
G. Rahmathulla, Nicholas Marko, R. Weil (2013)
Cerebral radiation necrosis: A review of the pathobiology, diagnosis and management considerationsJournal of Clinical Neuroscience, 20
-
Farzin Imani, F. Boada, F. Lieberman, D. Davis, J. Mountz (2014)
Molecular and metabolic pattern classification for detection of brain glioma progression.European journal of radiology, 83 2
-
R. Young, Ajay Gupta, A. Shah, J. Graber, Zhigang Zhang, Weiji Shi, A. Holodny, A. Omuro (2011)
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastomaNeurology, 76
-
Stephen Price, R. Jena, N. Burnet, T. Carpenter, J. Pickard, J. Gillard (2007)
Predicting patterns of glioma recurrence using diffusion tensor imagingEuropean Radiology, 17
-
Hirotaka Fudaba, T. Shimomura, T. Abe, H. Matsuta, Y. Momii, Kenji Sugita, H. Ooba, T. Kamida, T. Hikawa, M. Fujiki (2014)
Comparison of Multiple Parameters Obtained on 3T Pulsed Arterial Spin-Labeling, Diffusion Tensor Imaging, and MRS and the Ki-67 Labeling Index in Evaluating Glioma GradingAmerican Journal of Neuroradiology, 35
-
M. Koshy, J. Villano, T. Dolecek, A. Howard, U. Mahmood, S. Chmura, R. Weichselbaum, B. McCarthy (2012)
Improved survival time trends for glioblastoma using the SEER 17 population-based registriesJournal of Neuro-Oncology, 107
-
H. Okada, M. Weller, Raymond Huang, G. Finocchiaro, M. Gilbert, W. Wick, B. Ellingson, N. Hashimoto, I. Pollack, A. Brandes, E. Franceschi, C. Herold‐Mende, L. Nayak, A. Panigrahy, W. Pope, R. Prins, J. Sampson, P. Wen, D. Reardon (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.The Lancet. Oncology, 16 15
-
K. Kamada, K. Houkin, H. Abe, Y. Sawamura, T. Kashiwaba (1997)
Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy.Neurologia medico-chirurgica, 37 3
-
H. Thomsen, E. Steffensen, E. Larsson (2012)
Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomasActa Radiologica, 53
-
Leland Hu, L. Baxter, D. Pinnaduwage, D. Pinnaduwage, Tom Paine, J. Karis, B. Feuerstein, K. Schmainda, A. Dueck, J. Debbins, Kris Smith, P. Nakaji, J. Eschbacher, S. Coons, J. Heiserman (2010)
Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment GliomasAmerican Journal of Neuroradiology, 31
-
S. Thust, S. Thust, S. Heiland, A. Falini, H. Jager, H. Jager, A. Waldman, P. Sundgren, C. Godi, V. Katsaros, A. Ramos, N. Bargalló, M. Vernooij, T. Yousry, M. Bendszus, M. Smits (2018)
Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practiceEuropean Radiology, 28
-
W. Taal, D. Brandsma, H. Bruin, J. Bromberg, A. Swaak-Kragten, W. Eijkenboom, M. Bent (2007)
The incidence of pseudo-progression in a cohort of malignant glioma patients treated with chemo-radiation with temozolomideJournal of Clinical Oncology, 25
-
T. Ryken, N. Aygun, J. Morris, M. Schweizer, R. Nair, Cassandra Spracklen, S. Kalkanis, J. Olson (2014)
The role of imaging in the management of progressive glioblastomaJournal of Neuro-Oncology, 118
-
Praneil Patel, H. Baradaran, D. Delgado, G. Askin, P. Christos, A. Tsiouris, Ajay Gupta (2017)
MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysisNeuro-Oncology, 19
-
Shanshan Jiang, Tianyu Zou, C. Eberhart, M. Villalobos, H. Heo, Yi Zhang, Yu Wang, Xianlong Wang, Hao Yu, Yongxing Du, P. Zijl, Z. Wen, Jinyuan Zhou (2017)
Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRIMagnetic Resonance in Medicine, 78
-
Leland Hu, Zachary Kelm, P. Korfiatis, A. Dueck, Christian Elrod, B. Ellingson, T. Kaufmann, J. Eschbacher, J. Karis, Kris Smith, Peter Nakaji, Debra Brinkman, D. Pafundi, L. Baxter, Bradley Erickson (2015)
Impact of Software Modeling on the Accuracy of Perfusion MRI in GliomaAmerican Journal of Neuroradiology, 36
-
C. Reimer, Katerina Deike, Markus Graf, P. Reimer, B. Wiestler, R. Floca, P. Kickingereder, H. Schlemmer, W. Wick, M. Bendszus, A. Radbruch (2017)
Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response mapsPLoS ONE, 12
-
T. Kimura, K. Sako, Y. Tohyama, S. Aizawa, H. Yoshida, T. Aburano, K. Tanaka, T. Tanaka (2003)
Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: Value of proton magnetic resonance spectroscopyActa Neurochirurgica, 145
-
N. Galldiks, I. Law, W. Pope, J. Arbizu, K. Langen (2016)
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapyNeuroImage : Clinical, 13
-
P. Wen, D. MacDonald, D. Reardon, T. Cloughesy, A. Sorensen, E. Galanis, J. Degroot, W. Wick, M. Gilbert, A. Lassman, C. Tsien, T. Mikkelsen, Eric Wong, M. Chamberlain, R. Stupp, K. Lamborn, M. Vogelbaum, M. Bent, Susan Chang (2010)
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 11
-
W. Nailon (2010)
Texture Analysis Methods for Medical Image Characterisation -
Hatef Mehrabian, K. Desmond, H. Soliman, A. Sahgal, G. Stanisz (2017)
Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation TransferClinical Cancer Research, 23
-
Xintao Hu, Kelvin Wong, Geoffrey Young, Lei Guo, Stephen Wong (2011)
Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastomaJournal of Magnetic Resonance Imaging, 33
-
A. Prager, N. Martínez, K. Beal, A. Omuro, Zhigang Zhang, R. Young (2015)
Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic EvidenceAmerican Journal of Neuroradiology, 36
-
B. Dijken, P. Laar, G. Holtman, A. Hoorn (2017)
Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysisEuropean Radiology, 27
-
M. Chamberlain, M. Glantz, L. Chalmers, A. Horn, A. Sloan (2007)
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastomaJournal of Neuro-Oncology, 82
-
Jinyuan Zhou, E. Tryggestad, Z. Wen, B. Lal, Tingting Zhou, R. Grossman, Silun Wang, K. Yan, D. Fu, E. Ford, B. Tyler, J. Blakeley, J. Laterra, P. Zijl (2010)
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptidesNature medicine, 17
-
M. Chernov, M. Hayashi, M. Izawa, M. Usukura, S. Yoshida, Y. Ono, Y. Muragaki, O. Kubo, T. Hori, K. Takakura (2006)
Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastasesBrain Tumor Pathology, 23
-
M. Reuter, E. Gerstner, O. Rapalino, T. Batchelor, B. Rosen, B. Fischl (2014)
Impact of MRI head placement on glioma response assessmentJournal of Neuro-Oncology, 118
-
Saulo Lacerda, M. Law (2009)
Magnetic resonance perfusion and permeability imaging in brain tumors.Neuroimaging clinics of North America, 19 4
-
Jessica Narloch, S. Farber, S. Sammons, F. McSherry, J. Herndon, J. Hoang, F. Yin, J. Sampson, P. Fecci, K. Blackwell, J. Kirkpatrick, Grace Kim (2017)
Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosisNeuro-Oncology, 19
-
D. Fujimoto, R. Eyben, I. Gibbs, Steven Chang, Gordon Li, G. Harsh, S. Hancock, N. Fischbein, S. Soltys (2017)
Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occurJournal of Neuro-Oncology, 136
-
K. Reddy, D. Westerly, Changhu Chen (2013)
MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high‐grade gliomasJournal of Medical Imaging and Radiation Oncology, 57
-
M. Viallon, V. Cuvinciuc, B. Delattre, L. Merlini, I. Barnaure-Nachbar, Seema Toso-Patel, M. Becker, K. Lovblad, S. Haller (2015)
State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applicationsNeuroradiology, 57
-
B. Ellingson, P. Wen, T. Cloughesy (2017)
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical TrialsNeurotherapeutics, 14
-
H. Okada, M. Weller, Raymond Huang, G. Finocchiaro, M. Gilbert, W. Wick, B. Ellingson, N. Hashimoto, I. Pollack, A. Brandes, E. Franceschi, C. Herold‐Mende, L. Nayak, A. Panigrahy, W. Pope, R. Prins, J. Sampson, P. Wen, D. Reardon (2015)
NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUPNeuro-oncology, 17
- Publisher
- Wiley
- Copyright
- © 2018 International Society for Magnetic Resonance in Medicine
- ISSN
- 1053-1807
- eISSN
- 1522-2586
- DOI
- 10.1002/jmri.26171
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Journal of Magnetic Resonance Imaging – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ; ;